The 3-D Surgical Navigation System prototype has received a Red Dot Best of the Best Design Concept award for 2015, according to a press release by Cirle, originator of the technology.The Red Dot: Best of the Best award was given as top prize in the international competition’s Lifescience category, one of 31 categories represented.
Eye Surgeon Found Guilty of Bogus Diagnoses and Surgeries
David Ming Pon, MD, lied to patients that they had age-related wet macular degeneration and then faked laser photocoagulation, according to federal prosecutors. Medscape Medical News
ENV515 from Envisia meets primary efficacy endpoint in phase 2a glaucoma trial
ENV515 achieved its primary efficacy endpoint in reducing IOP in a phase 2a glaucoma clinical trial, according to an Envisia Therapeutics press release.The propriety, fully biodegradable PRINT travoprost formulation is designed to sustain IOP reduction…
AAO, other groups urge CMS to delay stage 3 Meaningful Use requirements
Ophthalmologists are struggling to meet attestation requirements of the Meaningful Use program for electronic health record adoption, the American Academy of Ophthalmology informed the CMS.According to a statement from the AAO, a coalition of medical s…
Walmart Outlines New Ways It Is Helping Customers Live Healthy Lives
BENTONVILLE, Ark.–(BUSINESS WIRE)–Building on its commitment to making healthcare and healthier food more affordable and accessible, Walmart today outlined additional ways the company is helping its customers live healthier lives. The retailer will focus on preventive care and supporting overall well-being across its entire assortment – in stores and online – through in-store events, online education and an expanded assortment of products and services solutions. Customers will see Walmart’s c
Ursapharm and Novaliq enter exclusive partnership, launch EvoTears
Novaliq and Ursapharm have entered an exclusive European partnership agreement and together have launched EvoTears, an over-the-counter treatment for evaporative dry eye disease.Under the agreement, Ursapharm obtains the exclusive license to commercialize Novaliq’s EvoTears, a multi-dose, non-aqueous, non-preserved lubricant eye drop, according to a press release from Novaliq.